|
ATBPF
|
If it is only 20-30% of patients get strong pain relief from ATB346, the p...
|
|
ATBPF
|
Unfortunately, no one can tell the probability of success. P-value means only...
|
|
ATBPF
|
If you do read ATE-346 study (the British one) in details, you would realize...
|
|
ATBPF
|
Yah. The drop was expected but we don't know when it happens. It might...
|
|
ATBPF
|
For ATE-346, of course it couldn't skip PII, where safty is one of their...
|
|
ATBPF
|
Double-blinded is important because it can differentiate true medicine...
|
|
ATBPF
|
BTW, while safety test is mandatory, efficacy test is not. You can even skip...
|
|
ATBPF
|
Two reasons for repeating the test: 1. it was not a "double blind"...
|
|
ATBPF
|
If you do look for facts, the fact is that 12 people show average pain relief...
|
|
ATBPF
|
Nothing wrong here. One lot is 50 instead of 100 for ATE.
|
|
PMN
|
valuation = future value * discount factor (time value) * probability of...
|
|
ATBPF
|
You are such a NICE person spending tons of time trying to save the people...
|
|
ATBPF
|
Two facts. Firstly, ATE has reached a regional deal with Kwang Dong...
|
|
ATBPF
|
Investors natuarally be optimistc. Otherwise, they wouldn't bet their...
|
|
ATBPF
|
Thanks. If it is in-the-red since IPO, it is a positive signal to me...
|
|
ATBPF
|
What matters is whether ATE346 be a safe NSAID drug with efficacy. Other than...
|
|
ATBPF
|
to be honest, if you can raise enought money to complete phase III, i.e...
|
|
ATBPF
|
why friends of the management team line up to buy more shares at .25...
|
|
ATBPF
|
The management just did what they should do - to keep the company afloat. If...
|
|
ATBPF
|
Sounds great! but, Nov 5th of which year?
|